Reliance Retail Ventures Limited is planning a determined push into the $150 billion diagnostic healthcare segment with the acquisition of a majority stake in a pure-play diagnostic services company, with a cheque size in the range of INR 10.00 billion - INR 30.00 billion, sources said. The Mukesh Ambani-owned retailer is looking for a player with a pan-India presence, sources said. The Reliance Industries Limited (NSEI:RELIANCE) subsidiary has online pharmacy Netmeds in its portfolio, which also offers pathology services through its tie-ups with companies such as Thyrocare, Healthians and a few others.

The intent now is to have its own diagnostic company with a large network of physical laboratories across the country offering a range of services and scale that up, people aware of developments said. The company is understood to be actively evaluating opportunities in the segment and a deal is likely in the medium term, depending on due diligence and the valuations. RIL did not respond to an email seeking clarification on its proposed plans.